Record Year & Double-Digit Growth Outlook For This Long-Time Compounder

Outperforming on all metrics

A company whose management team is crazy about return on capital, maximizing shareholder value creation, viewing share repurchases, dividends, growth CAPEX as one homogeneous pool of capital to be deployed: we love it! Let’s review the earnings report and FY24 outlook for one of our most reliable compounders.